The president indicated that duties on chips would be “approximately 100%” earlier this month.

The investment includes increasing manufacturing and research and development capabilities at its Reedsville, Pennsylvania, ...

The fresh funding will support pivotal trials in progress and commercialization preparations at the two heart-focused ...

Apple said it was able to bring a redesigned blood oxygen feature to its devices after a recent U.S. customs ruling.

By combining surgical video with other insights, Jegatheeswaran hopes Johnson & Johnson can support better outcomes in ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

Days into the job, CEO Stephen From said the company no longer expects to begin a clinical trial for its robotic system by ...

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

The records system is available for U.S. ambulatory providers, pending regulatory approval. Oracle plans to launch in the acute care market next year.

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...